| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 17.60 | 0.00 (0.00%) | 13.66 - 17.60 | 0.0 |
Market data as of 12:00AM 05/20/13. Quotes are delayed by at least 15 min.
The investment seeks capital appreciation through investments primarily in growth companies that benefit from technology advances. The fund invests primarily in equity securities in the form of common stock of high growth businesses selected for their capital appreciation potential. It will invest at least 65% of its assets in equity securities of companies with market capitalizations between $1 billion and $15 billion at the time of purchase. The fund seeks to purchase securities that the Adviser expects could increase in value 100% within four to five years.
| Total Return | 17.81% |
|---|---|
| Yield (Trailing 12 Mo.) | 0.00% |
| Expense Ratio | 1.13% |
| Front Load | None |
| Deferred Load | None |
| Minimum Investment | $1,000,000 |
| Management Tenure | 7 Years |
| Fund Inception | 05/29/2009 |
| Timeframe | BIOIX | S&P 500 | Mid-Cap Growth |
|---|---|---|---|
| 1 Month | -0.42% | 1.93% | 0.34% |
| 3 Month | 4.20% | 7.18% | 4.65% |
| Year-to-Date | 8.49% | 12.74% | 11.11% |
| 1 Year | 7.02% | 16.89% | 11.31% |
| 3 Year | 11.51% | 12.80% | 11.39% |
| 5 Year | 6.58% | 5.21% | 5.29% |
| 10 Year | 13.48% | 7.88% | 9.69% |
| Since Inception | 17.81% | 10.38% | -- |
| Basic Materials | 0.00% | |
|---|---|---|
| Consumer Cyclical | 18.16% | |
| Financial Services | 1.15% | |
| Real Estate | 4.23% | |
| Consumer Defensive | 0.87% | |
| Healthcare | 7.22% | |
| Utilities | 2.14% | |
| Communication Services | 2.59% | |
| Energy | 6.78% | |
| Industrials | 20.92% | |
| Technology | 35.94% |
| By Percent | Short | 0% | Long | Net | |
|---|---|---|---|---|---|
| Stock | -- | 91.49 | 91.49 | ||
| Bond | -- | 0.00 | 0.00 | ||
| Other | -- | 1.05 | 1.05 | ||
| Foreign Stock | -- | 6.69 | 6.69 | ||
| Foreign Bond | -- | 0.00 | 0.00 | ||
| Total | -- | 99.23 | 99.23 | ||
| Cash | -- | 0.77 | 0.77 | ||
| Total Net Assets | $397.50M |
|---|---|
| Total Stock Holdings | 58 |
| Total Bond Holdings | 0 |
| Valuation | BIOIX | Category Range |
|---|---|---|
| Price/Earnings | 30.14 | |
| Price/Book | 4.83 | |
| Price/Sales | 3.19 | |
| Price/Cash Flow | 17.26 | |
| Dividend Yield | 0.36 | |
| LT Earnings | 16.1 | |
| Historical Earnings | 21.57 | |
| Sales Growth | 11.17 | |
| Cash-Flow Growth | 16.85 | |
| Book-Value Growth | 14.41 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
 |  |  |
| Rating | vs Category | |
|---|---|---|
| Overall |  | |
| Risk | Avg | |
| Return | Avg |
| Pretax Return | 11.51% |
|---|---|
| Tax-adjusted Return | 11.42% |
| Tax Cost Ratio | 0.08% |
| Potential Cap Gains | 20.68% |
